Trial Profile
A prospective, open-label study to evaluate the treatment with levodopa carbidopa infusion therapy in patients with Parkinson's disease.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 17 Dec 2015
Price :
$35
*
At a glance
- Drugs Levodopa/carbidopa (Primary)
- Indications Parkinson's disease
- Focus Therapeutic Use
- 17 Dec 2015 New trial record